JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001, of Argos Therapeutics Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: February 21, 2014
LCC Legacy Holdings Inc. | ||
By: | /s/ Xxxxx Xxxxxxx | |
Name: Xxxxx Xxxxxxx | ||
Title: VP Finance | ||
Lumira Capital Investment Management Inc. | ||
By: | /s/ Xxxxx Xxxxxxx | |
Name: Xxxxx Xxxxxxx | ||
Title: VP Finance | ||
/s/ Xxxxxx Xxxxx | ||
Xxxxxx Xxxxx | ||
/s/ Xxxxxx Xxxx | ||
Xxxxxx Xxxx | ||
/s/ Xxxxxxxx Xxxxxxxx | ||
Xxxxxxxx Xxxxxxxx | ||
/s/ Xxxxx van der Xxxxxx | ||
Xxxxx van der Velden | ||
/s/ Xxxxx X. Xxxxxxxxx | ||
Xxxxx X. Xxxxxxxxx | ||
/s/ Xxxxx Xxxxxxx | ||
Xxxxx Xxxxxxx |